India's Sudeep Pharma drops on lower quarterly profit, margin

Sudeep Pharma

22/12/2025 06:51

** Sudeep Pharma SUDP.NS falls as much as 6% to 645.35 rupees; last down nearly 3%

** Recently-listed co's profit down 6.2% y/y, even as revenue rises 9.3% in Sept quarter

** EBITDA margin contracts to 38% from 43.4% a year ago

** Co says return ratios compressed primarily due to ongoing greenfield capex and recently acquired Nutrition Supply Services, expects stronger momentum in second half of fiscal year 2025-26

** Stock up 8.8% from its issue price of 593 rupees since listing last month

 (Reporting by Vivek Kumar M)

 ((VivekKumar.M@thomsonreuters.com;))